Work

Neuroendocrine tumor (NET) progression of disease during or within one year after completion of therapy with Lu-177-DOTATATE

Year: 2025
Type: conference-abstract
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4408303340
Cites:
Cited by:
Related to: 10